Edoxaban vs DAPT for Leaflet Thrombosis and Cerebral Thromboembolism After TAVR
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Circulation
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Edoxaban versus Dual Antiplatelet Therapy for Leaflet Thrombosis and Cerebral Thromboembolism after TAVR: The ADAPT-TAVR Randomized Clinical Trial
Circulation 2022 Apr 04;[EPub Ahead of Print], DW Park, JM Ahn, DY Kang, KW Kim, HJ Koo, DH Yang, SC Jung, B Kim, YTA Wong, CCS Lam, WH Yin, J Wei, YT Lee, HL Kao, MS Lin, TY Ko, WJ Kim, SH Kang, SC Yun, SA Lee, E Ko, H Park, DH Kim, JW Kang, JH Lee, SJ ParkFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.